Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Targeting NIK in the Noncanonical NF-κB Pathway Reveals Inflammatory Mechanisms in Diverse Cellular Compartments Relevant to Inflammatory Bowel Disease

  • By

  • Hao Xu

  • Dun Li

  • Jie Liang

  • Nathan Adamson

  • Alexis Scherl

  • Luli Zou

  • Crystal Hu

  • Elaine E. Storm

  • Christian B. Cox

  • Adam Johnson

  • Mary E. Keir

  • Hua Zhang

  • Saiyu Hang

  • June 9, 2026

Share

Objective:

To investigate the role of NF-κB-inducing kinase (NIK) in inflammatory bowel disease (IBD) pathogenesis.

Key Findings:
  • NIK deletion in epithelial cells disrupted M-cell differentiation and reduced recruitment of Th17 cells.
  • NIK activity in dendritic cells amplified CD40-mediated innate immune responses.
  • NIK skewed T cell differentiation toward pro-inflammatory Th1 cells, reducing regulatory T cells.
  • Systemic NIK deletion and pharmacologic inhibition with NIK-smi reduced inflammation and improved colon histopathology in preclinical models.
  • Optimal dosing regimen for NIK-smi was identified as 200 mg/kg BID.
Interpretation:

Limitations:
  • The study primarily utilized preclinical models, which may not fully replicate human IBD.
  • The long-term effects and safety of NIK inhibition in humans remain to be established.
Conclusion:

Original Source(s)

Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease

  • by Hao Xu, Dun Li, Jie Liang, Nathan Adamson, Alexis Scherl, Luli Zou, Crystal Hu, Elaine E. Storm, Christian B. Cox, Adam Johnson, Mary E. Keir, Hua Zhang, Saiyu Hang

  • June 9, 2026

Related Content

Estrogen receptors and the NRF2 pathway: bridging hormonal regulation and stress response in the gut

Safety and efficacy of advanced combination therapies for treating inflammatory bowel disease in adults: a systematic review and meta-analysis

Association of serological markers with endoscopic mucosal healing and disease activity in patients with inflammatory bowel disease: a retrospective study